We have upgraded our services to allow you to submit and track your applications on the spot. To start please click here
- Vilazodone 28.08.2023
- Mitavipat 28.08.2023
- Daratumumab 26.07.2023
- Galcanezumab 26.07.2023
- Lxekizumab 26.07.2023
- Ocrelizumab 26.07.2023
- Secukinumab 26.07.2023
- Tepotinib 26.07.2023
- Glucagon-like Peptide-1(GLP-1) Receptor agonist 24.05.2023
- Dupilmuab 15.05.2023
- Risankizumab 15.05.2023
- Ustekinumab 15.05.2023
- Nusirensen Indication 28.03.2023
- Anti-Vascular Endothelial Growth Factor (VEGF) Therapy for Diabetic and Senile Macular Degeneration Coverage of Mastectomy in Gynecomastia 10.01.2023
- Guselkumab 28.12.2022
- Crizanlizumab 28.12.2022
- Vedolizumab 28.12.2022
- Canakinumab 28.12.2022
- PPI Indicators Coverage in OP Setting 28.12.2022
- Palivizumab indication 13.05.2022
- Parenteral immunoglobulin 13.05.2022
- Hepatitis C Adjunct Therapy 28.01.2019
- Mepolizumab Indications 05.12.2019
- Filgrastim Indications 12.11.2018
- Growth Hormone Indications 30.08.2018
- Prostate Cancer Pharmacological Treatment 01.08.2018
- Liraglutide for Obesity Management 21.12.2017
- PCSK9 Inhibitors Indications 22.08.2016
- Botulinum Toxin 17.10.2016
- Anti-Tumor Necrosis Factor Alfa (TNF-a) 15.07.2014
- Phenytoin Indications 15.07.2014
